Behavioral Effects of d-Amphetamine in Humans: Influence of Subclinical Levels of Inattention and Hyperactivity

被引:3
|
作者
Sevak, Rajkumar J.
Stoops, William W.
Rush, Craig R. [1 ,2 ,3 ]
机构
[1] Univ Kentucky, Albert B Chandler Med Ctr, Dept Behav Sci, Coll Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Albert B Chandler Med Ctr, Dept Psychiat, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA
关键词
substance abuse; attention-deficit hyperactivity disorder; behavior; d-amphetamine; hyperactivity; inattention; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DISCRIMINATIVE-STIMULUS; SUBSTANCE USE; METHYLPHENIDATE; TRIAZOLAM; ABUSE; METHAMPHETAMINE; DEPENDENCE; NICOTINE; SYMPTOMS;
D O I
10.3109/00952990.2010.494213
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: Several studies suggest a link between stimulant abuse and attention-deficit hyperactivity disorder (ADHD) symptoms (e. g., inattention and hyperactivity). To further assess the nature of this relationship, the present study examined the association between subclinical symptoms of inattention and hyperactivity and the behavioral effects of d-amphetamine. Methods: Participants were classified into a High-(n = 8) or Low-Score (n = 9) group based on their responses on a rating scale that assessed inattention and hyperactivity symptoms. Results: The participants did not differ across the High-Score and Low-Score groups in their ability to discriminate d-amphetamine. The participants in the High-Score group were significantly more sensitive to the positive participant-rated effects of d-amphetamine (e. g., Good Effects, Like Drug), but less sensitive to drug-induced increases in blood pressure and heart rate. Conclusion: The selective increase in positive subjective effects of d-amphetamine suggests that individuals with subclinical inattention and hyperactivity symptoms may have increased vulnerability to stimulant abuse.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 50 条
  • [1] Oxazepam does not modulate the behavioral effects of d-amphetamine in humans
    Lile, JA
    Stoops, WW
    Wagner, FP
    Glaser, PEA
    Rush, CR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 82 (02) : 270 - 279
  • [2] Subjective and behavioral effects of repeated d-amphetamine in humans
    Wachtel, SR
    de Wit, H
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (03): : 271 - 281
  • [3] Inattention, impulsive action, and subjective response to D-amphetamine
    Weafer, Jessica
    de Wit, Harriet
    DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (01) : 127 - 133
  • [4] Cocaine Choice in Humans During D-Amphetamine Maintenance
    Rush, Craig R.
    Stoops, William W.
    Sevak, Rajkamur J.
    Hays, Lon R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 152 - 159
  • [5] Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule
    Sevak, Rajkumar J.
    Stoops, William W.
    Glaser, Paul E. A.
    Hays, Lon R.
    Rush, Craig R.
    BEHAVIOURAL PHARMACOLOGY, 2010, 21 (08): : 745 - 753
  • [6] Comparison of the Behavioral and Cardiovascular Effects of Intranasal and Oral d-Amphetamine in Healthy Human Subjects
    Lile, Joshua A.
    Babalonis, Shanna
    Emurian, Cleeve
    Martin, Catherine A.
    Wermeling, Daniel P.
    Kelly, Thomas H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06) : 888 - 898
  • [7] The cognitive and behavioral effects of D-amphetamine and nicotine sensitization in adult zebrafish
    Cleal, Madeleine
    Fontana, Barbara D.
    Parker, Matthew O.
    PSYCHOPHARMACOLOGY, 2021, 238 (08) : 2191 - 2200
  • [8] DISCRIMINATIVE STIMULUS EFFECTS OF D-AMPHETAMINE, METHYLPHENIDATE, AND DIAZEPAM IN HUMANS
    HEISHMAN, SJ
    HENNINGFIELD, JE
    PSYCHOPHARMACOLOGY, 1991, 103 (04) : 436 - 442
  • [9] Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults
    Makris, Angela P.
    Rush, Craig R.
    Frederich, Robert C.
    Taylor, Alisia C.
    Kelly, Thomas H.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2007, 15 (02) : 123 - 133
  • [10] The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans
    Silber, B.
    Croft, R.
    Camfield, D. A.
    Downey, L. A.
    Papafotiou, K.
    Stough, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (07) : 492 - 500